Literature DB >> 30807702

Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness.

Li-Juan Kang1, Zi-Han Yu1, Jun Cai1, Rui He1, Jun-Tao Lu1, Chen Hou1, Qing-Shan Wang1,2, Xiao-Qing Li1,2, Rui Zhang1,2, Yu-Mei Feng1,2.   

Abstract

FOXF2 and FOXQ1, forkhead box transcription factor superfamily members, are encoded by neighboring genes located on human chromosome 6p25.3 and play opposite roles in epithelial-mesenchymal transition (EMT) and metastasis in basal-like breast cancer (BLBC). However, the relationship between FOXF2 and FOXQ1 in cancer remains unknown. Here, we found mutual transcriptional repression between FOXF2 and FOXQ1, and the reciprocal negative feedback loop controlled EMT, aggressiveness, and chemoresistance in BLBC cells. We further demonstrated that FOXF2 recruited nuclear receptor corepressor 1 and histone deacetylase 3 to the FOXQ1 promoter to inhibit its transcription in BLBC cells, but FOXQ1 did not exert such an effect on FOXF2. Our findings reveal novel mechanisms underlying the determination of BLBC aggressiveness and the transrepressive function of FOXF2 in a basal-like cell subtype-specific manner. Therefore, blocking the vicious cycle of the abnormal reciprocal feedback loop between FOXF2 and FOXQ1 to induce cell differentiation and restore tissue homeostasis is a promising strategy for the treatment of aggressive BLBC.-Kang, L.-J., Yu, Z.-H., Cai, J., He, R., Lu, J.-T., Hou, C., Wang, Q.-S., Li, X.-Q., Zhang, R., Feng, Y.-M. Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness.

Entities:  

Keywords:  EMT; HDAC3; NCoR1; chemoresistance

Year:  2019        PMID: 30807702     DOI: 10.1096/fj.201801916R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  10 in total

1.  FOXF2 deficiency accelerates the visceral metastasis of basal-like breast cancer by unrestrictedly increasing TGF-β and miR-182-5p.

Authors:  Jun-Tao Lu; Cong-Cong Tan; Xiao-Ran Wu; Rui He; Xiao Zhang; Qing-Shan Wang; Xiao-Qing Li; Rui Zhang; Yu-Mei Feng
Journal:  Cell Death Differ       Date:  2020-05-18       Impact factor: 15.828

2.  Stroke-associated intergenic variants modulate a human FOXF2 transcriptional enhancer.

Authors:  Jae-Ryeon Ryu; Suchit Ahuja; Corey R Arnold; Kyle G Potts; Aniket Mishra; Qiong Yang; Muralidharan Sargurupremraj; Douglas J Mahoney; Sudha Seshadri; Stéphanie Debette; Sarah J Childs
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-22       Impact factor: 12.779

3.  Foxf2 represses bone formation via Wnt2b/β-catenin signaling.

Authors:  Tomoyuki Tanaka; Akira Takahashi; Yutaka Kobayashi; Masanori Saito; Sun Xiaolong; Chen Jingquan; Yoshiaki Ito; Tsuyoshi Kato; Hiroki Ochi; Shingo Sato; Toshitaka Yoshii; Atsushi Okawa; Peter Carlsson; Hiroyuki Inose
Journal:  Exp Mol Med       Date:  2022-06-06       Impact factor: 12.153

4.  Identification of testicular Foxq1 as a critical modulator of lactate metabolism in mouse Sertoli cells.

Authors:  Zetao Liu; Mingyou Yuan; Xiangxiang Meng; Haiwen Bie; Shaobo Yao
Journal:  Histochem Cell Biol       Date:  2021-06-05       Impact factor: 4.304

Review 5.  FOXF2 acts as a crucial molecule in tumours and embryonic development.

Authors:  Weihan He; Yuanbo Kang; Wei Zhu; Bolun Zhou; Xingjun Jiang; Caiping Ren; Weihua Guo
Journal:  Cell Death Dis       Date:  2020-06-05       Impact factor: 8.469

6.  FOXF2 reprograms breast cancer cells into bone metastasis seeds.

Authors:  Shuo Wang; Gui-Xi Li; Cong-Cong Tan; Rui He; Li-Juan Kang; Jun-Tao Lu; Xiao-Qing Li; Qing-Shan Wang; Pei-Fang Liu; Qiong-Li Zhai; Yu-Mei Feng
Journal:  Nat Commun       Date:  2019-06-20       Impact factor: 14.919

7.  The regulatory roles and mechanisms of the transcription factor FOXF2 in human diseases.

Authors:  Qiong Wu; Wei Li; Chongge You
Journal:  PeerJ       Date:  2021-03-02       Impact factor: 2.984

8.  FOXQ1 is Differentially Expressed Across Breast Cancer Subtypes with Low Expression Associated with Poor Overall Survival.

Authors:  Fahed A Elian; Ubah Are; Sunita Ghosh; Paulo Nuin; Tim Footz; Todd P W McMullen; David N Brindley; Michael A Walter
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-03-01

Review 9.  Epithelial-mesenchymal transition and its transcription factors.

Authors:  Pallabi Debnath; Rohit Singh Huirem; Paloma Dutta; Santanu Palchaudhuri
Journal:  Biosci Rep       Date:  2022-01-28       Impact factor: 3.840

10.  Transcriptomic Analysis Exploring the Molecular Mechanisms of Hanchuan Zupa Granules in Alleviating Asthma in Rat.

Authors:  Hailong Yin; Yanbo Fan; Dandan Mu; Fei Song; Fang Tian; Qiang Yin
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-02       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.